Key result
Higher systolic BP variability linked to ~8.1-fold higher mortality per mmHg in ANCA-associated vasculitis.
Why the study?
Long-term systolic blood pressure variability may better predict outcomes than mean blood pressure in AAV patients, but its impact on mortality is unclear.
Does visit-to-visit systolic blood pressure variability increase the risk of all-cause mortality in patients with ANCA-associated vasculitis?
Cohort (n=95)
Yes
Does visit-to-visit systolic blood pressure variability increase the risk of all-cause mortality in patients with ANCA-associated vasculitis?
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“[The study] findings support the integration of BP variability assessment into long-term management strategies aimed at stabilizing BP and mitigating CV [cardiovascular] burden in AAV [antineutrophil cytoplasmic antibody-associated vasculitis].”
In patients with ANCA-associated vasculitis, long-term visit-to-visit systolic blood pressure variability is a strong independent predictor of all-cause mortality, outperforming mean systolic blood pressure.
Objectives Antineutrophil cytoplasmic antibody–associated vasculitis (AAV) is associated with increased cardiovascular risk, related to persistent inflammation and endothelial dysfunction. Long -term systolic BP variability (SBPV), reflecting vascular damage, may predict outcomes better than mean BP. We investigated the impact of BP control and visit-to-visit BP variability (VVV), on all-cause mortality in AAV patients during maintenance therapy. Methods We retrospectively studied 95 AAV patients followed at three Italian nephrology centers. SBPV was defined as the standard deviation (SD) of ≥4 systolic BP measurements within 12 months from the first SBPV assessment. Patients were stratified by SBPV tertiles. The primary outcome was all-cause mortality. Results Over a median follow-up of 78 months, 14 patients (14.7%) died. Deceased patients were older and had higher PP and VVV. Hypertension prevalence increased across SBPV tertiles (35%, 62%, 69%; p = 0.02). Mortality rose from 6% in the lowest to 34.5% in the highest SBPV tertile (Fisher’s exact, p = 0.001). Time-averaged systolic BP was not associated with mortality. Conversely, each 5-mmHg increase in SBPV was associated with a twofold higher risk of death (HR 2.03, 95% CI 1.29–3.20; p = 0.002). SBPV remained significantly associated with outcome after full multivariable adjustment, including age, sex, myeloperoxidase (MPO) positivity, eGFR, PP, and proteinuria (adjusted HR 8.06 per 1 mmHg, 95% CI 1.42-45.54; p = 0.02). Conclusion In AAV patients, increased VVV was associated with all-cause mortality outperforming mean systolic BP. Further research is needed to confirm the impact of variable blood pressure on patient outcomes in AAV.
No takes yet. Share an insight, caveat, or question.
Bussalino et al. (2026) conducted a cohort in ANCA-associated vasculitis (n=95). Systolic blood pressure variability vs. Lowest systolic blood pressure variability tertile was evaluated on All-cause mortality (adjusted HR 8.06, 95% CI 1.42-45.54, p=0.02). In patients with ANCA-associated vasculitis, higher systolic blood pressure variability was associated with increased all-cause mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: